TRIF adaptor signaling is important in abdominal aortic aneurysm formation

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 561-568

  Vorkapic, Emina ^a,b   Lundberg, Anna M ^c   Mäyränpää, Mikko I ^d,e   Eriksson, Per ^b   Wågsäter, Dick ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiontensin II; Inflammation; Toll like receptor; Vascular disease

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN II; APOLIPOPROTEIN E; BETA INTERFERON; CD11B ANTIGEN; CD68 ANTIGEN; ELASTIN; INTERLEUKIN 10; MACROPHAGE ELASTASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCOLLAGEN; PROCOLLAGEN IALPHA1; PROTEIN LYSINE 6 OXIDASE; RANTES; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOLIPOPROTEIN; CD3 ANTIGEN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; TICAM-1 PROTEIN, MOUSE; TICAM1 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA DISSECTION; AORTA MEDIA; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR INFLAMMATION; CD3+ T LYMPHOCYTE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART PROTECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; AORTA; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANGIOTENSIN II; ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTA; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS; APOLIPOPROTEINS E; ELASTIN; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84934985469     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.06.014     Document Type: Article

References (25)

1. Shimizu K., Mitchell R.N., Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2006, 26(5):987-994.
2. Michel J.B., Martin-Ventura J.L., Egido J., et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc. Res. 2011, 90(1):18-27.
3. Lopez-Candales A., Holmes D.R., Liao S., Scott M.J., Wickline S.A., Thompson R.W. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am. J. Pathol. 1997, 150(3):993-1007.
4. Katsargyris A., Klonaris C., Bastounis E., Theocharis S. Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease?. Expert Opin. Ther. Targets 2008, 12(11):1329-1346.
5. Michelsen K.S., Doherty T.M., Shah P.K., Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J.Immunol. 2004, 173(10):5901-5907.
6. Lundberg A.M., Hansson G.K. Innate immune signals in atherosclerosis. Clin. Immunol. 2010, 134(1):5-24.
7. Edfeldt K., Swedenborg J., Hansson G.K., Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002, 105(10):1158-1161.
8. Owens A.P., Rateri D.L., Howatt D.A., et al. MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through toll-like receptors 2 and 4. Arterioscler. Thromb. Vasc. Biol. 2011, 31(12):2813-2819.
9. Pryshchep O., Ma-Krupa W., Younge B.R., Goronzy J.J., Weyand C.M. Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation 2008, 118(12):1276-1284.
10. Frantz S., Ertl G., Bauersachs J. Mechanisms of disease: toll-like receptors in cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(8):444-454.
11. Arancibia S.A., Beltran C.J., Aguirre I.M., et al. Toll-like receptors are key participants in innate immune responses. Biol. Res. 2007, 40(2):97-112.
12. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4(7):499-511.
13. McGettrick A.F., O'Neill L.A. Localisation and trafficking of toll-like receptors: an important mode of regulation. Curr. Opin. Immunol. 2010, 22(1):20-27.
14. Youn H.S., Lee J.Y., Saitoh S.I., et al. Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 2006, 72(7):850-859.
15. Bjorkbacka H., Kunjathoor V.V., Moore K.J., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 2004, 10(4):416-421.
16. Michelsen K.S., Wong M.H., Shah P.K., et al. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 2004, 101(29):10679-10684.
17. Lundberg A.M., Ketelhuth D.F., Johansson M.E., et al. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc. Res. 2013, 99(2):364-373.
18. Daugherty A., Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2004, 24(3):429-434.
19. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J.Clin. Investig. 2000, 105(11):1605-1612.
20. Manning M.W., Cassi L.A., Huang J., Szilvassy S.J., Daugherty A. Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc. Med. 2002, 7(1):45-54.
21. Rateri D.L., Howatt D.A., Moorleghen J.J., Charnigo R., Cassis L.A., Daugherty A. Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am. J. Pathol. 2011, 179(3):1542-1548.
22. Saraff K., Babamusta F., Cassis L.A., Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23(9):1621-1626.
23. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11(2):85-97.
24. Yoshida S., Fuster J.J., Walsh K. Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. Atherosclerosis 2014, 235(2):339-346.
25. Zimmer S., Steinmetz M., Asdonk T., et al. Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ. Res. 2011, 108(11):1358-1366.